Statins and oral biofilm: Simvastatin as a promising drug to control periodontal dysbiosis

Simple item page
dc.contributor.authorRafaela Durrer Parolina de Carvalho
dc.contributor.authorJéssica de Andrade Moreno
dc.contributor.authorSindy Magri Roque
dc.contributor.authorDaniel Cheuk Hong Chan
dc.contributor.authorWilly Bustillos Torrez
dc.contributor.authorRafael Nóbrega Stipp
dc.contributor.authorBruno Bueno‐Silva
dc.contributor.authorPatrícia Oliveira de Lima
dc.contributor.authorKarina Cogo
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T14:19:55Z
dc.date.available2026-03-22T14:19:55Z
dc.date.issued2022
dc.descriptionCitaciones: 13
dc.description.abstractSimvastatin showed antimicrobial and antibiofilm activity against oral bacteria and may contribute to the control of dysbiosis, and may be considered in clinical studies as an adjuvant in the treatment of periodontitis.
dc.identifier.doi10.1111/odi.14446
dc.identifier.urihttps://doi.org/10.1111/odi.14446
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/45891
dc.language.isoen
dc.publisherWiley
dc.relation.ispartofOral Diseases
dc.sourceUniversidade Estadual de Campinas (UNICAMP)
dc.subjectStreptococcus sanguinis
dc.subjectMicrobiology
dc.subjectFusobacterium nucleatum
dc.subjectStreptococcus oralis
dc.subjectPrevotella intermedia
dc.subjectBiofilm
dc.subjectActinomyces naeslundii
dc.subjectStreptococcus mutans
dc.subjectAntimicrobial
dc.subjectAmoxicillin
dc.titleStatins and oral biofilm: Simvastatin as a promising drug to control periodontal dysbiosis
dc.typearticle

Files

Collections

Artículo Científico Publicado